European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, rising 0.12% to 1,505.82 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies Grifols (GRFS) and Genfit (GNFT), which rose 2% and 1.8% respectively. They were followed by biopharmaceutical company argenx (ARGX) and pharmaceutical company Novo Nordisk (NVO), which increased 1.4% and 0.4% respectively.

The decliners from continental Europe were led by 3D printer company Materialise (MTLS) and semiconductor company Sequans Communications (SQNS), which fell 10.7% and 2.7% respectively. They were followed by oil and gas company TotalEnergies (TTE) and telecommunications company Nokia (NOK), which were down 2.6% and 1.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and telecommunications operator Vodafone Group (VOD), which climbed 13.3% and 3% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and NuCana (NCNA), which were up 2.6% and 0.2% respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which dropped 4.6% and 4% respectively. They were followed by software firm Endava (DAVA) and cruise line operator Carnival (CUK), which lost 2% and 1.9% respectively.